The purpose was to identify and eliminate dormant PV conduction and triggered AF from non-PV foci.
I
t has been 15 years since the mechanism of paroxysmal atrial fibrillation (AF) was attributed to triggering foci, largely within pulmonary veins (PVs) (1); since then, catheter ablation procedures for AF have risen exponentially with isolation of PV electrical activity from the left atrium (LA) forming the cornerstone of most ablation strategies (2) . However, procedural success rates appear to have reached an efficacy "ceiling" with w50% of patients experiencing recurrences at 1 year off antiarrhythmic drugs, even at experienced centers (3) . Incomplete efficacy is likely due to our inability to create durable transmural lesions with subsequent recovery of electrical conduction responsible for both intermediate and long-term AF recurrence following PV isolation (4) (5) (6) . Much work has recently focused on elucidating the triggering and sustaining mechanisms for AF beyond the PVs, with appreciation that the existence of organized re-entrant circuits (rotors) or focal impulses are not necessarily constrained to the PVs, are biatrially distributed (even in paroxysmal AF), and can be targeted with focal ablation in an attempt to improve outcomes (7).
In the context of such discussion, it is timely that Kuroi et al. (8) , in this issue of JACC: Clinical Electrophysiology, report their attempt at improving ablation outcomes in 464 consecutive patients with paroxysmal AF who, firstly, underwent circumferential PV isolation using the double-circular mapping catheter technique, followed by systematic provocation with high-dose adenosine (30 mg intravenous) injection and concomitant isoproterenol infusion.
The purpose was to identify and eliminate dormant PV conduction and triggered AF from non-PV foci.
The salient findings were that:
1. Acute PV conduction recovery was present in 30% of patients during the first procedure, and 85% of patients had spontaneous PV conduction recovery discovered at a re-do procedure; 2. Non-PV foci were uncovered in 4.3% of patients during their first and in 6.9% of patients during their second procedure; these were localized to either atria (62%) or to the superior vena cava (SVC) (38%). All foci were successfully ablated in the first procedure; however, 3 of 8 foci (38%) were not successfully ablated during the second procedure, all of which were non-SVC origin; 3. One-year single and multiple procedure success rates off antiarrhythmic medications were 55% and w67%, respectively. Notably, identification and elimination of non-PV foci did not enhance singleprocedure success, but paradoxically, conferred worse outcomes predominantly driven by an w4-fold higher risk of AF recurrence in patients with triggering foci from atrial sites. By contrast, elimination of SVC triggers via SVC isolation yielded similar outcomes to patients without any triggers beyond the PVs.
In an attempt to identify nontransmural lesions, adenosine is often used to hyperpolarize damaged cells such that they transiently regain electrical excitability (9); isoproterenol provides no incremental benefit for this purpose (10) . In the present study This is not surprising because isolation of the SVC musculature is a straightforward endpoint. However, one of the most intriguing findings in this study was that the majority of non-PV foci were from atrial 
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